Share
High Content Imaging Market: By Type (Instruments, Consumables, Software, Services and Accessories), By Application (Toxicity Studies, Compound Profiling, Target Identification and Validation, Primary Screening and Secondary Screening), And Region - Global Analysis Of Market Size, Share & Trends For 2019-2020 And Forecasts To 2031
[170+ Pages Research Report] High Content Imaging Market to surpass USD 847.54 million by 2031 from USD 847.54 million in 2021 at a CAGR of 11.4% throughout the forecast period 2021-31
High content screening, also known as cellomics, is an image-based screening technique that measures physical and biochemical properties in cells and organisms. To obtain quantitative data from cell populations, it employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluorescence imaging, and other visualisation processes. The image capture programme, its evaluation, and data storage are all part of the high content screening. In high content screening, cells are first produced with the substance and then their arrangements and molecular components are examined after a period of time. High-content imaging can be used to analyse whole cells or specific components of cells while simultaneously collecting data on a variety of factors.
Global High Content Imaging to surpass USD 1679.24 million by 2031 from USD 847.54 million in 2021 at a CAGR of 11.4% in the coming years, i.e., 2021-31. Increasing advancements in informatics solutions and imaging instruments, as well as the market's increasing need for cost containment in pharmaceutical research and development, are expected to drive demand. Furthermore, rising levels of government investment in the development of the healthcare sector, an increase in the number of patients suffering from chronic diseases requiring intensive treatment, and an increase in the need for determining and studying toxicity levels in the early stages of drug discovery are some of the major factors that will likely augment the growth of the high content screening market.
Get More Information - Download Free Sample
Global High Content Imaging market is classified on the basis of Type into Instruments, Consumables, Software, Services and Accessories. The instruments market accounted for the largest share of the high content screening market, owing to advances in instrumentation and automation techniques, as well as the high prices of high content screening instruments. This market's expansion can be attributed to technological advancements in image acquisition, data analysis, and storage capabilities, as well as the need to obtain information on changes in cell morphology via high-quality images.
Based on application, global High Content Imaging Market is fragmented into Toxicity Studies, Compound Profiling, Target Identification and Validation, Primary Screening and Secondary Screening and Others. During the forecast period, the primary and secondary screening application segment is expected to grow at the fastest CAGR. The rapid growth can be attributed primarily to the widespread use of high content imaging for secondary screening. The presence of a large number of potential drug candidates for target-specific delivery can also be attributed to growth in the primary and secondary screening segments.
Get More Information - Download Free Sample
The global high content screening market is expected to grow lucratively as a result of the increasing need for the development of new drug molecules as a result of the presence of obsolete drug therapies with lower potency. Technological advancements such as the use of multicoloured fluorescence-based reagents, polarisation techniques, automated imaging technology, and flow cytometry are expected to fuel market growth even further. Furthermore, benefits associated with these innovations, such as use in gene identification and neonatal development studies, as well as improved drug penetrability, are expected to provide growth potential to the market over the forecast period.
The need for cost containment in pharma R&D, growth in funding for cellular research, and technological advancements in High Content Imaging solutions are expected to drive the high content screening market during the forecast period. Increasing the number of contract research organization providing high content imaging services, as well as the increasing number of applications of high content screening in personalised medicine is expected to contribute to the growth of the high content screening market in the forecasted period.
The high cost of High Content Imaging instruments, as well as a scarcity of knowledgeable and skilled personnel for operating high-content screening instruments, is expected to limit market growth to some extent.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Global High Content Imaging market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. High R&D spending, the presence of major pharmaceutical market players, and increased government support are some of the factors contributing to North America's large market share. Increased drug discovery research, government initiatives, and a growing focus of multinational corporations on emerging markets are also factors driving market.
Diagnostic service providers are providing test services to healthcare providers as a result of the spread of the coronavirus disease (COVID-19). They are also using High Content Imaging to detect the efficacy of COVID-19 drugs in patients, which is expected to drive market growth.
REPORT ATTRIBUTE |
DETAILS |
|
Market size value in 2021 |
USD 847.54 million |
|
Revenue forecast in 2031 |
USD 1679.24 million |
|
Growth Rate |
CAGR of 11.4% from 2021 to 2031 |
|
Base year for estimation |
2020 |
|
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2030 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Type, Application and Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
|
Key companies profiled |
Danaher Corp. GE Healthcare, Instrument Systems, Perkinelmer Inc., Thermo Fisher Scientific Inc., Becton Dickinson, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Yokogawa Electric Corporation and Other Prominent Players |
High Content Imaging market size was estimated at USD 847.54 million in 2021 and is expected to reach USD 1679.24 million in 2031.
High content screening, also known as cellomics, is an image-based screening technique that measures physical and biochemical properties in cells and organisms
Primary Screening and Secondary Screening and instruments accounted for the largest High Content Imaging market share.
Key players: Danaher Corp. GE Healthcare, Instrument Systems, Perkinelmer Inc., Thermo Fisher Scientific Inc. are the key players in the High Content Imaging market.
The need for cost containment in pharma R&D, growth in funding for cellular research, and technological advancements in High Content Imaging solutions are expected to drive the high content screening market during the forecast period.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
